老年性甲状腺功能亢进症采取^(131)I治疗的临床效果  

Clinical effect of ^(131)I in the treatment of senile hyperthyroidism

作　　者：张颖娟 

机构地区：[1]陕西省渭南市第二医院内分泌科,陕西渭南714000

出　　处：《临床医学研究与实践》2018年第5期28-29,共2页Clinical Research and Practice

摘　　要：目的评价^(131)I治疗老年甲状腺功能亢进症的临床效果。方法选取本院收治的老年性甲状腺功能亢进症患者98例为研究对象,分为对照组与治疗组,各49例。对照组采取丙基硫酸氧嘧啶治疗,治疗组采取^(131)I治疗。比较两组患者的临床效果。结果治疗后,治疗组患者的血清TT_3、TT_4、FT_3、FT_4明显低于对照组,s TSH水平明显高于对照组(P<0.05)。治疗组的甲状腺肿大率为55.10%,明显低于对照组的77.55%(P<0.05)。治疗组总有效率明显高于对照组(P<0.05);两组甲减发生率比较,差异不显著(P>0.05)。结论 ^(131)I治疗老年性甲状腺功能亢进症可有效改善甲状腺功能,临床疗效显著,值得临床应用。Objective To evaluate the clinical efficacy of ^（131） I in the treatment of senile hyperthyroidism. Methods Ninety-eight senile hyperthyroidism patients were enrolled in this study, and all the patients were divided into control group and treatment group, with 49 cases in each group. The control group was treated with propoxylated pyrimidine, and the treatment group was treated with ^（131） I. The clinical effects of the two groups were compared. Results After treatment, the levels of serum TT_3, TT_4, FT_3, FT_4 of the treatment group were lower, and the s TSH level was higher than those of the control group（P〈0.05）. The rate of thyromegaly of the treatment group was 55.10%, which was lower than 77.55% of the control group（P〈0.05）. The total effective rate of the treatment group was higher than that of the control group（P〈0.05）. There was no significant difference in incidence of hypothyroidism between the two groups（P〈0.05）. Conclusion ^（131） I in the treatment of senile hyperthyroidism can effectively improve thyroid function of the patients, it has significant clinical effect, which is worthy of clinical application.

关 键 词：老年性甲状腺功能亢进 131I 甲状腺肿大 

分 类 号：R817.5[医药卫生—影像医学与核医学] R581.1[医药卫生—放射医学]